Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

London

Encode: AI for Science London Launch Celebration

Pillar is celebrating the launch of Encode: AI for Science, a fellowship program dedicated to accelerating scientific translation through AI. On March 20th, join them [...]

Go to Top